SAINTE-FOY, QUEBEC--(Marketwire - April 09, 2008) - Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, today announced its results for the fourth quarter and the fiscal year ended December 31, 2007.
